McCracken Joseph S

CIK 00016324544 companiesLANGHORNE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001632454

Recent Transactions

50 trades

Award
Savara Inc$SVRA
Common Stock
2025-12-09+40,000→ 300,837 total
Purchase
Savara Inc$SVRA
Common Stock
2025-05-29$2.08/sh+10,000→ 260,837 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−3,328→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−5,684→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−3,345→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−2,910→ 0 total
Award
Savara Inc$SVRA
Common Stock
2024-12-12+40,000→ 250,837 total
Disposition to Issuer
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-12-12−3,431→ 0 total
Disposition to Issuer
LUMOS PHARMA, INC.
Common Stock
2024-12-12−15,721→ 0 total
Purchase
Savara Inc$SVRA
Common Stock
2024-11-19$2.95/sh+20,000→ 210,837 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2024-06-05+3,328→ 3,328 total
Award
Savara Inc$SVRA
Common Stock
2023-12-14+22,500→ 190,837 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2023-05-10+3,345→ 3,345 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2022-12-13+40,000→ 40,000 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-11-16$5.03/sh+4,000→ 15,721 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2022-08-25$8.60/sh+3,170→ 11,721 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2022-05-05+3,431→ 3,431 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2021-12-14+40,000→ 40,000 total
Disposition to Issuer
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-08-27−48,500→ 0 total
Disposition to Issuer
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-08-27−41,890→ 0 total
Disposition to Issuer
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-08-27$4.81/sh−48,500→ 0 total
Disposition to Issuer
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-08-27−10,000→ 0 total
Disposition to Issuer
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-08-27−48,500→ 0 total
Purchase
LUMOS PHARMA, INC.
Common Stock
2021-08-11$7.55/sh+7,475→ 8,551 total
Award
LUMOS PHARMA, INC.
Common Stock
2021-05-20+367→ 1,076 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2021-05-20+2,910→ 2,910 total
Purchase
Savara Inc$SVRA
Common Stock
2021-03-15$1.45/sh+68,965→ 168,337 total
Award
Kindred Biosciences, Inc.
Stock Option (right to buy)
2021-01-20+48,500→ 48,500 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2020-12-16+40,000→ 40,000 total
Award
LUMOS PHARMA, INC.
Common Stock
2020-04-03+709→ 709 total
Award
LUMOS PHARMA, INC.
Stock Option (Right to Buy)
2020-04-03+5,684→ 5,684 total
Award
Kindred Biosciences, Inc.
Stock Option (right to buy)
2020-01-17+48,500→ 48,500 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2019-12-20+12,000→ 12,000 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2019-07-05$1.76/sh+9,034→ 99,372 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2019-07-05−5,860→ 0 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2019-07-05$0.82/sh+21,682→ 81,548 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2019-07-05−9,034→ 1,807 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2019-07-05−2,930→ 0 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2019-07-05$0.82/sh+2,930→ 84,478 total
Exercise/Conversion
Savara Inc$SVRA
Stock Option (Right to Buy)
2019-07-05−21,682→ 0 total
Exercise/Conversion
Savara Inc$SVRA
Common Stock
2019-07-05$1.46/sh+5,860→ 90,338 total
Award
Kindred Biosciences, Inc.
Stock Option (right to buy)
2019-02-01+48,500→ 48,500 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2018-12-13+12,000→ 12,000 total
Award
Kindred Biosciences, Inc.
Stock Option (Right to Buy)
2018-06-22+10,000→ 10,000 total
Award
Kindred Biosciences, Inc.
Stock Option (Right to Buy)
2018-04-20+41,890→ 41,890 total
Award
Savara Inc$SVRA
Stock Option (Right to Buy)
2017-12-17+3,750→ 3,750 total
Disposition to Issuer
Nexvet Biopharma plc
Ordinary Shares
2017-07-31$6.72/sh−16,400→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-07-01−3,600→ 0 total
Exercise/Conversion
Nexvet Biopharma plc
Ordinary Shares
2017-07-01$0.13/sh+3,600→ 16,400 total
Exercise/Conversion
Nexvet Biopharma plc
Restricted Share Units
2017-06-30−500→ 0 total

Companies

Recent Filings

Address

ONE SUMMIT SQUARE, 1717 LANGHORNE NEWTOWN ROAD, SUITE 300

LANGHORNE, PA, 19047

View on SEC.gov